T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.93% |
| 2 | Consumer Discretionary | 13.87% |
| 3 | Financials | 13.55% |
| 4 | Industrials | 11.68% |
| 5 | Technology | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Ryder
R
$10.1B
| $4.78M | ﹤0.01% |
80,075
+300
| +0.4% | +$18K |
|
1427
NVR
NVR
$16.8B
| $4.75M | ﹤0.01% |
5,163
+600
| +13% | +$543K |
|
1428
MarketAxess Holdings
MKTX
$5.72B
| $4.68M | ﹤0.01% |
77,900
+66,200
| +566% | +$3.54M |
|
|
MXIM
1429
DELISTED
Maxim Integrated Products
MXIM
| $4.68M | ﹤0.01% |
156,921
+5,100
| +3% | +$145K |
|
|
HK
1430
DELISTED
Halcon Resources Corporation
HK
| $4.63M | ﹤0.01% |
6,065
-5,777
| -49% | -$5.27M |
|
1431
Stratasys
SSYS
$767M
| $4.61M | ﹤0.01% |
45,500
+2,400
| +6% | +$232K |
|
1432
Gran Tierra Energy
GTE
$336M
| $4.53M | ﹤0.01% |
63,936
+1,030
| +2% | +$67.6K |
|
|
ILG
1433
DELISTED
ILG, Inc Common Stock
ILG
| $4.49M | ﹤0.01% |
190,104
+8,000
| +4% | +$176K |
|
|
MKTG
1434
DELISTED
RESPONSYS INC COM STK (CA)
MKTG
| $4.46M | ﹤0.01% |
+270,000
| New | +$3.99M |
|
1435
Erie Indemnity
ERIE
$13.5B
| $4.43M | ﹤0.01% |
61,100
| – | – |
|
|
TPH
1436
DELISTED
Tri Pointe Homes
TPH
| $4.38M | ﹤0.01% |
298,700
+26,300
| +10% | +$402K |
|
1437
Zebra Technologies
ZBRA
$17.9B
| $4.34M | ﹤0.01% |
95,325
-2,600
| -3% | -$120K |
|
|
PAL
1438
DELISTED
NORTH AMERICAN PALLADIUM LTD
PAL
| $4.24M | ﹤0.01% |
4,415,370
-69,100
| -2% | -$74.1K |
|
1439
Unisys
UIS
$210M
| $4.23M | ﹤0.01% |
168,039
-6,700
| -4% | -$168K |
|
|
X
1440
DELISTED
US Steel
X
| $4.2M | ﹤0.01% |
204,095
+2,310
| +1% | +$43.5K |
|
1441
Abercrombie & Fitch
ANF
$4.84B
| $4.16M | ﹤0.01% |
117,460
-1,200
| -1% | -$53.1K |
|
1442
Oshkosh
OSK
$9.41B
| $4.15M | ﹤0.01% |
84,800
| – | – |
|
1443
Sabra Healthcare REIT
SBRA
$5.15B
| $4.14M | ﹤0.01% |
179,898
-5,300
| -3% | -$131K |
|
|
AERL
1444
DELISTED
ASIA ENTERTAINMENT & RES LTD ORD SHS(CYM)
AERL
| $4.09M | ﹤0.01% |
1,049,400
-600
| -0.1% | -$2.43K |
|
1445
Chemed
CHE
$7.02B
| $4.08M | ﹤0.01% |
57,000
-500
| -0.9% | -$35.6K |
|
|
PGTI
1446
DELISTED
PGT, Inc.
PGTI
| $4.07M | ﹤0.01% |
+411,013
| New | +$4.14M |
|
1447
Richardson Electronics
RELL
$300M
| $4.05M | ﹤0.01% |
356,380
| – | – |
|
|
KW
1448
DELISTED
Kennedy-Wilson Holdings
KW
| $4.03M | ﹤0.01% |
217,243
| – | – |
|
|
ECYT
1449
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $4.02M | ﹤0.01% |
301,900
+1,100
| +0.4% | +$17.4K |
|
1450
Prothena Corp
PRTA
$466M
| $4M | ﹤0.01% |
197,784
+61,900
| +46% | +$1.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.